BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 day ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 day ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 day ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 day ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago
ADVERTISEMENT
Market News

Neovasc (NVCN) Q4 2019 Earnings Snapshot

— Neovasc (NASDAQ: NVCN) reported a comprehensive loss of $1.45 per share for Q4 2019 vs. a loss of $5.07 per share in the prior-year quarter. — Revenue rose 8% to $0.57 million vs. $1.16 million expected. — Expenses declined 6% to $10.03 million. — The company stated that it started the year with strong […]

$NVCN March 30, 2020 1 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results
NYSE
$NVCN · Earnings

— Neovasc (NASDAQ: NVCN) reported a comprehensive loss of $1.45 per share for Q4 2019 vs. a loss of $5.07 per share in the prior-year quarter. — Revenue rose 8% to $0.57 million vs. $1.16 million expected. — Expenses declined 6% to $10.03 million. — The company stated that it started the year with strong […]

· March 30, 2020

— Neovasc (NASDAQ: NVCN) reported a comprehensive loss of $1.45 per share for Q4 2019 vs. a loss of $5.07 per share in the prior-year quarter.

— Revenue rose 8% to $0.57 million vs. $1.16 million expected.

— Expenses declined 6% to $10.03 million.

— The company stated that it started the year with strong Reducer revenues in January and February and were on track for the best revenue quarter ever, until the effects of the COVID-19 crisis were abruptly felt. 

— NVCN stock declined about 9% during the after-hours of trading.

ADVERTISEMENT

ADVERTISEMENT